Induction Chemoradiotherapy Followed by Surgical Resection for Clinical T3 or T4 Locally Advanced Non–Small Cell Lung Cancer
暂无分享,去创建一个
J. Soh | S. Toyooka | S. Miyoshi | K. Matsuo | K. Kiura | H. Date | K. Shien | M. Takemoto | T. Oto | M. Yamane
[1] J. Sculier. Nonsmall cell lung cancer , 2013, European Respiratory Review.
[2] K. Kerr,et al. Guidelines on the radical management of patients with lung cancer , 2010, Thorax.
[3] Keitaro Matsuo,et al. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] D. Mannino. COPD as a disease of children: hype or hope for better understanding? , 2010, Thorax.
[5] R. Mirimanoff,et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. , 2009, The Lancet. Oncology.
[6] V. Rusch,et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial , 2009, The Lancet.
[7] J. Jett,et al. Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.
[8] C. Stevens,et al. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.
[9] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[10] T. Okamoto,et al. Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non-small cell lung cancer. , 2007, The Journal of thoracic and cardiovascular surgery.
[11] V. Rusch,et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Quynh-Thu Le,et al. Non-small cell lung cancer: Clinical practice guidelines in oncology , 2006 .
[13] L. Voltolini,et al. Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection. , 2006, Lung cancer.
[14] D. Wood,et al. Surgical Management of T3 and T4 Lung Cancer , 2005, Clinical Cancer Research.
[15] Y. Nishiwaki,et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. , 2005, The Journal of thoracic and cardiovascular surgery.
[16] K. Kiura,et al. Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer , 2004, British Journal of Cancer.
[17] K. Eguchi,et al. Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer , 2003, British Journal of Cancer.
[18] P. Yildiz,et al. Comparison of clinical and surgical-pathologic staging of the patients with non-small cell lung carcinoma. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[19] K. Kiura,et al. Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N2 non-small cell lung cancer , 2002, British Journal of Cancer.
[20] P. Dartevelle,et al. Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[21] V. Rusch,et al. Extent of chest wall invasion and survival in patients with lung cancer. , 1999, The Annals of thoracic surgery.
[22] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[23] B. Yalcin,et al. Multidisciplinary management of lung cancer. , 2004, The New England journal of medicine.